Atorvastatin Calcium

Product NDC: 60760-709
11-digit product format: 607600709
Labeler code: 60760
Product ID: 60760-709_85cd3f96-b84a-f192-e053-2991aa0aee98
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Atorvastatin Calcium
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: St. Mary's Medical Park Pharmacy
Application: ANDA209288
Marketing category: ANDA
Marketing start: 2019-03-28
Marketing end: 0000-00-00
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 40 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	60760-709		D	Discontinued by firm		2026-08-17
excluded package	package	60760-709	60760-709-30	D	Discontinued by firm		2026-08-17

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A209288-001	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21
A209288-002	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21
A209288-003	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21
A209288-004	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A209288-001	AB
A209288-002	AB
A209288-003	AB
A209288-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2018-12-21	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A209288-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209288-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209288-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A209288-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A209288-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209288-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209288-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209288-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209288-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209288-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209288-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209288-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209288-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209288-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209288-004	AB	1	`d8e5a09893c0…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60760-709-30	EA - Each	60760-709	aa5559ba-faae-40a6-b147-ec34657add95	1	2019-05-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60760-709	ATORVASTATIN CALCIUM TABLET, FILM COATED [ST. MARY'S MEDICAL PARK PHARMACY]	1	Legacy NDC	20190412_85cd2fb8-d6b2-c3a3-e053-2991aa0ac18c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Atorvastatin Calcium	ATORVASTATIN CALCIUM	REMEDYREPACK INC.	09cb8375-075c-47e8-a4eb-8ac667ed849e	2026-07-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Northwind Health Company, LLC	c9f55cb6-a41b-dd27-e053-2a95a90aaeb7	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Northwind Health Company, LLC	f3084cae-db82-4e6f-e053-2995a90aa36a	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Northwind Health Company, LLC	da6b77a5-2093-b7f7-e053-2995a90ab10d	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	QPharma, Inc.	bd216f5d-f319-7d8d-e053-2a95a90aa9ce	2025-12-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	QPharma, Inc.	c0e2a5d0-1aa3-e131-e053-2a95a90a9870	2025-12-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	REMEDYREPACK INC.	57f9b462-f08e-483c-9b64-b7e4c8d46927	2025-09-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Asclemed USA, Inc.	60d51f39-8086-4434-affe-88ab8ca0c7e5	2025-05-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Ascend Laboratories, LLC	67e60880-091a-4df7-8696-6e6c42a490e2	2025-04-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Bryant Ranch Prepack	2035c49b-f319-4dce-bf1c-c2f64e786fb7	2025-01-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	95729689-8055-45ae-e053-2995a90a919f	2024-06-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	8ee8b455-625c-ead6-e053-2a95a90aed29	2024-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	862f9f27-c645-2d2e-e053-2991aa0a96b9	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc.	862f58d1-476c-2c90-e053-2991aa0ab821	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	1cc2dd41-a465-45b6-a80a-67c41af29cf8	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	2ad89657-cc95-44a0-af6a-ee756526aa10	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	103cc381-3266-409d-bdc2-1de620bae355	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	e52b4b11-9618-4787-ae67-44e4a3166dfb	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	0ec97c59-9d17-45f8-93f9-2c1f0361cb75	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288
Atorvastatin Calcium	ATORVASTATIN CALCIUM	A-S Medication Solutions	e6d068ed-f9d2-4fd1-9755-b76bea89725e	2024-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209288 application number: ANDA209288

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
60760-709-30	60760070930	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-709-30)	2019-03-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Atorvastatin Calcium	St. Mary's Medical Park Pharmacy \| Alkem Laboratories Limited	2019-04-05	HUMAN PRESCRIPTION DRUG LABEL	1